Active surveillance for favorable risk prostate cancer: Rationale, risks, and results.

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Abstract Text:

Laurence Klotz,Laurence Klotz,

Active surveillance for favorable risk prostate cancer has become increasingly popular in populations where prostate cancer screening is widespread, due to evidence that prostate cancer screening results in the detection of disease that is not clinically significant in many patients (i.e., untreated, would not pose a threat to health). This approach is supported by data demonstrating that patients who fall into the category of clinically insignificant disease can be identified with reasonable accuracy, and that patients who are initially classified as low risk who reclassify over time as higher risk and are then treated more aggressively are in most cases still cured. An active surveillance approach means (1) identifying patients who have a low likelihood of disease progression during their lifetime, based on clinical and pathologic features of the disease and patient age and comorbidity; (2) monitoring closely over time, (3) establishing reasonable criteria for intervention, which will both identify more aggressive disease in a timely fashion, and not result in excessive treatment, and (4) meeting the communication challenge to reduce the psychological burden of living with untreated cancer. The results of active surveillance, the criteria for patient selection, and the appropriate triggers for intervention are reviewed.

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Publishing Authors By Initials

L Klotz,L Klotz,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Urologic oncology

VOLUME: 25

Page Numbers: 505-9

Journal Abbreviation: Urol. Oncol.

ISSN: 1078-1439

DAY: 30

MONTH: 11

YEAR: 2007

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9805460

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Active surveillance for favorable risk prostate cancer: Rationale, risks, and results. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Active surveillance for favorable risk prostate cancer: Rationale, risks, and results.

AFFILIATION: University of Toronto Division of Urology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Urol Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Active surveillance for favorable risk prostate cancer: Rationale, risks, and results Related Publications

• Active surveillance for favorable risk prostate cancer: Rationale, risks, and results.
• Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it?
• Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?
• An Sfi1p-Like Centrin-Binding Protein Mediates Centrin-Based Ca2+-Dependent Contractility in Paramecium tetraurelia.
• Antiarrhythmics : elimination and dosage considerations in hepatic impairment.
• Casting a wider net for countermeasure r&d funding decisions.
• Characterization of Two New Genes, amoR and amoD, in the amo Operon of the Marine Ammonia Oxidizer Nitrosococcus oceani ATCC 19707.
• Drug-related risks.
• Epidermal growth factor- and stress-induced loss of gap junctional communication is mediated by ERK-1/ERK-2 but not ERK-5 in rat liver epithelial cells.
• How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?
• Nomadic or sessile: can Kupffer cells function as portals for malaria sporozoites to the liver?
• North American blastomycosis (Gilchrist's disease) a study of the disease from a review of the literature.
• North American blastomycosis (Gilchrist's disease) an analysis of Canadian reports and description of a new case of the systemic type.
• Pencil penetrates orbit.
• Some aspects of the action of sulfonamides; rate-controlling processes in growth studies with Escherichia coli.
• Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor.
• The bridging function of clinical pharmacology.
• The impact of genome analyses on our understanding of ammonia-oxidizing bacteria.
• Thorn in body causing abscess after 21 years.
• Transport studies with 5-aminosalicylate.
• Unchanged serum levels of advanced glycation endproducts in patients with liver disease.
• [Healthy lifestyles and help-seeking in males - no improvement in sight.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]